Literature DB >> 4003975

Verapamil and myoclonic dystonia.

C B Hicks, K Abraham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4003975     DOI： 10.7326/0003-4819-103-1-154_1

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

Review 1.  A comparative review of the adverse effects of calcium antagonists.

Authors:  H T Dougall; J McLay
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

Review 2.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

3.  Behavioral performance effects of verapamil in normotensive and renovascular hypertensive baboons.

Authors:  J S Turkkan; R D Hienz
Journal:  Integr Physiol Behav Sci       Date:  1992 Apr-Jun

4.  [Seizure and non-cardiogenic pulmonary edema after intoxication].

Authors:  M Sawatzki; O Kummer; S Krähenbühl; M Siegemund
Journal:  Internist (Berl)       Date:  2010-04       Impact factor: 0.743

5.  Functional and Molecular Properties of DYT-SGCE Myoclonus-Dystonia Patient-Derived Striatal Medium Spiny Neurons.

Authors:  Anna Kutschenko; Selma Staege; Karen Grütz; Hannes Glaß; Norman Kalmbach; Thomas Gschwendtberger; Lisa M Henkel; Johanne Heine; Anne Grünewald; Andreas Hermann; Philip Seibler; Florian Wegner
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.